It is generally understood that the human immune system deteriorates over time and that this results in an increased frequency of and susceptibility to infectious disease, autoimmunity and cancer, and in poorer responses to vaccines.

Although there is considerable evidence that older adults may deal poorly with novel infectious disease, evidence for the other claims is surprisingly weak. Disentangling the contributions of age from a lifetime’s exposure to pathogens and other environmental challenges is no simple matter.

In this presentation, Dr. Graham Pawelec, MA, PhD, professor of Experimental Immunology at the Center for Medical Research at the University of Tübingen in Germany, will use longitudinal study data to address the impact of immune aging on responses of cancer patients to immunomodulatory antibody therapy.

Registration not required. Refreshments will be provided.

URL: https://mira.mcmaster.ca/news-events/event/2018/08/20/scientific-events/mira-mirc-seminar-dr.-graham-pawelec